代谢综合征：从分子机制到新疗法。
Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies.
机构信息
Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, GA 30322, USA.
Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, SC 29208, USA.
出版信息
Int J Mol Sci. 2021 Sep 17;22(18):10038. doi: 10.3390/ijms221810038.
Abstract
The metabolic syndrome (MetS) consists of a cluster of metabolic abnormalities including central obesity, insulin resistance, glucose intolerance, hypertension, and atherogenic dyslipidemia [...].
摘要
代谢综合征（MetS）是一组代谢异常的综合征，包括中心性肥胖、胰岛素抵抗、葡萄糖耐量异常、高血压和致动脉粥样硬化性血脂异常等。
相似文献
1
Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies.代谢综合征：从分子机制到新疗法。
Int J Mol Sci. 2021 Sep 17;22(18):10038. doi: 10.3390/ijms221810038.
2
Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.ZDSD大鼠的特征：一种用于代谢综合征和2型糖尿病研究的转化模型。
J Diabetes Res. 2015;2015:487816. doi: 10.1155/2015/487816. Epub 2015 Apr 16.
3
Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.神经肾上腺素能功能障碍沿着糖尿病连续谱：肥胖代谢综合征患者的对比研究。
Diabetes. 2012 Oct;61(10):2506-16. doi: 10.2337/db12-0138. Epub 2012 Jun 4.
4
Is metabolic syndrome X an inflammatory condition?X综合征是一种炎症性疾病吗？
Exp Biol Med (Maywood). 2002 Dec;227(11):989-97. doi: 10.1177/153537020222701106.
5
Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.代谢综合征的病因：胰岛素抵抗、瘦素抵抗及其他因素的潜在作用
Ann N Y Acad Sci. 1999 Nov 18;892:25-44. doi: 10.1111/j.1749-6632.1999.tb07783.x.
6
The coming of age of the metabolic syndrome.代谢综合征的成年期
Diabetes Care. 2003 Nov;26(11):3180-1. doi: 10.2337/diacare.26.11.3180.
7
Redox implications in adipose tissue (dys)function--A new look at old acquaintances.脂肪组织（功能失调）中的氧化还原影响——对老相识的新审视。
Redox Biol. 2015 Dec;6:19-32. doi: 10.1016/j.redox.2015.06.018. Epub 2015 Jul 2.
8
The metabolic basis of atherogenic dyslipidemia.致动脉粥样硬化性血脂异常的代谢基础。
Clin Cornerstone. 2005;7(2-3):27-35. doi: 10.1016/s1098-3597(05)80065-1.
9
Metabolic Syndrome During Menopause.更年期的代谢综合征。
Curr Vasc Pharmacol. 2019;17(6):595-603. doi: 10.2174/1570161116666180904094149.
10
Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.评论：斯特拉兹尼基等人。糖尿病连续过程中的神经肾上腺素能功能障碍：肥胖代谢综合征受试者的比较研究。《糖尿病》2012年；61卷：2506 - 2516页。
Diabetes. 2013 Jan;62(1):e1. doi: 10.2337/db12-1087.
引用本文的文献
1
Doxorubicin-induced cardiometabolic disturbances: what can we do?多柔比星诱导的心脏代谢紊乱：我们能做些什么？
Front Clin Diabetes Healthc. 2025 Feb 14;6:1537699. doi: 10.3389/fcdhc.2025.1537699. eCollection 2025.
2
Sodium-Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome.钠-葡萄糖协同转运蛋白抑制剂：参与脂质代谢及治疗与代谢综合征相关的慢性肾脏病的细胞机制
Antioxidants (Basel). 2024 Jun 26;13(7):768. doi: 10.3390/antiox13070768.
3
The association between the triglyceride-glucose index and the risk of cardiovascular disease in US population aged ≤ 65 years with prediabetes or diabetes: a population-based study.在美国患有糖尿病前期或糖尿病的 ≤ 65 岁人群中，甘油三酯-葡萄糖指数与心血管疾病风险的关系：一项基于人群的研究。
Cardiovasc Diabetol. 2024 May 13;23(1):168. doi: 10.1186/s12933-024-02261-8.
4
Role of Chemerin and Perivascular Adipose Tissue Characteristics on Cardiovascular Risk Assessment by Arterial Stiffness Markers in Patients with Morbid Obesity.在病态肥胖患者中，趋化素和血管周围脂肪组织特征在通过动脉僵硬度标志物进行心血管风险评估中的作用。
J Clin Med. 2023 Apr 14;12(8):2885. doi: 10.3390/jcm12082885.
5
Remnant cholesterol can identify individuals at higher risk of metabolic syndrome in the general population.残胆固醇可识别一般人群中代谢综合征风险较高的个体。
Sci Rep. 2023 Apr 12;13(1):5957. doi: 10.1038/s41598-023-33276-y.
6
Editorial: Diet-microbe-host interactions in metabolic syndrome.社论：代谢综合征中的饮食-微生物-宿主相互作用
Front Nutr. 2023 Jan 18;10:1129200. doi: 10.3389/fnut.2023.1129200. eCollection 2023.
7
Role of Chemerin in Cardiovascular Diseases.凯莫瑞在心血管疾病中的作用。
Biomedicines. 2022 Nov 18;10(11):2970. doi: 10.3390/biomedicines10112970.
8
The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus.医生数字工具在 2 型糖尿病药物管理中的作用。
Medicina (Kaunas). 2022 Aug 6;58(8):1061. doi: 10.3390/medicina58081061.
9
Biological Determinants of Metabolic Syndrome in Visceral and Subcutaneous Adipose Tissue from Severely Obese Women.重度肥胖女性内脏和皮下脂肪组织中代谢综合征的生物学决定因素
Int J Mol Sci. 2022 Feb 21;23(4):2394. doi: 10.3390/ijms23042394.
10
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.代谢综合征：2021 年病理生理学和治疗管理的最新进展。
Int J Mol Sci. 2022 Jan 12;23(2):786. doi: 10.3390/ijms23020786.
本文引用的文献
1
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.肠促胰岛素（GIP和GLP-1）在代谢性疾病和心血管疾病中的演变历程：病理生理学最新进展
Diabetes Obes Metab. 2021 Sep;23 Suppl 3:5-29. doi: 10.1111/dom.14496.
2
Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review.表观遗传学、microRNA 与代谢综合征：全面综述。
Int J Mol Sci. 2021 May 10;22(9):5047. doi: 10.3390/ijms22095047.
3
COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic.新冠疫情编辑文章：新冠疫情爆发一年来代谢性疾病的机制联系与治疗挑战
Metabolism. 2021 Jun;119:154769. doi: 10.1016/j.metabol.2021.154769. Epub 2021 Mar 26.
4
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect.在2型糖尿病患者的真实世界中，利拉鲁肽通过降低小而密低密度脂蛋白来减少颈动脉内膜中层厚度：一种新的抗动脉粥样硬化作用。
Diabetes Ther. 2021 Jan;12(1):261-274. doi: 10.1007/s13300-020-00962-3. Epub 2020 Nov 18.
5
COVID-19 and diabetes management: What should be considered?2019冠状病毒病与糖尿病管理：应考虑哪些方面？
Diabetes Res Clin Pract. 2020 May;163:108151. doi: 10.1016/j.diabres.2020.108151. Epub 2020 Apr 17.
6
Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.糖尿病与新冠疫情：近期经验所得的见解如何指导未来管理
Metab Syndr Relat Disord. 2020 May;18(4):173-175. doi: 10.1089/met.2020.0037. Epub 2020 Apr 9.
7
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.度拉糖肽每周 1 次治疗 2 型糖尿病患者的代谢参数、内皮功能障碍和颈动脉内膜中层厚度：一项 8 个月前瞻性研究。
Diabetes Res Clin Pract. 2019 Mar;149:163-169. doi: 10.1016/j.diabres.2019.02.006. Epub 2019 Feb 10.
8
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.利拉鲁肽改善代谢综合征糖尿病患者的代谢参数及颈动脉内膜中层厚度：一项为期18个月的前瞻性研究。
Cardiovasc Diabetol. 2016 Dec 3;15(1):162. doi: 10.1186/s12933-016-0480-8.
9
Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome.抵抗素：一种炎症细胞因子。在心血管疾病、糖尿病和代谢综合征中的作用。
Curr Pharm Des. 2014;20(31):4961-9. doi: 10.2174/1381612819666131206103102.
10
Ethnic differences in serum lipoproteins and their determinants in South African women.南非女性血清脂蛋白及其决定因素的种族差异。
Metabolism. 2010 Sep;59(9):1341-50. doi: 10.1016/j.metabol.2009.12.018. Epub 2010 Jan 22.
Zotero 插件